Head injuries could be a risk factor for developing brain cancer

byUniversity College LondonCredit: Unsplash/CC0 Public DomainResearchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the develop

Updated on: January 07,2024

Head injuries could be a risk factor for developing brain cancer

byUniversity College LondonCredit: Unsplash/CC0 Public DomainResearchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the develop

Updated on:January 07,2024

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on: November 11,2024

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on:November 11,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on: January 10,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on:January 10,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on: September 27,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on:September 27,2024

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s

Updated on: December 28,2023

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s

Updated on:December 28,2023

'I'm not going to be cured'. How breast cancer awareness and support sidelines people with metastatic disease

by Sophie Lewis, Andrea Smith and Katherine Kenny,The ConversationCredit: AI-generated imageThere have been incredibleadvancesin breast cancer diagnosis and treatment in recent years

Updated on: March 14,2024

'I'm not going to be cured'. How breast cancer awareness and support sidelines people with metastatic disease

by Sophie Lewis, Andrea Smith and Katherine Kenny,The ConversationCredit: AI-generated imageThere have been incredibleadvancesin breast cancer diagnosis and treatment in recent years

Updated on:March 14,2024

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

November 2023Lara C. Pullen, PhDA new study reports on the long-term risk for coronary heart disease (CHD) in blood or marrow transplant (BMT) recipients and identifies individuals who are at high ris

Updated on: February 18,2024

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

November 2023Lara C. Pullen, PhDA new study reports on the long-term risk for coronary heart disease (CHD) in blood or marrow transplant (BMT) recipients and identifies individuals who are at high ris

Updated on:February 18,2024

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly

Updated on: January 02,2024

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly

Updated on:January 02,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on: March 30,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on:March 30,2024

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on: December 01,2024

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on:December 01,2024

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Updated on: January 26,2024

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Updated on:January 26,2024

These foods may up your odds for colon cancer

by Dennis Thompson, Healthday Reporter(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.These foods all

Updated on: April 14,2024

These foods may up your odds for colon cancer

by Dennis Thompson, Healthday Reporter(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.These foods all

Updated on:April 14,2024